To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FHL3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
285 supporting clones for gene FHL3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX332083 Neuroblastoma Cot 25-normalized .a 1 to 689 5 to 692       692/692
(100 %)
6 diff
(99.2 %id)
BX332105 Neuroblastoma Cot 25-normalized .a 1 to 699 5 to 702       702/702
(100 %)
1 diff
(99.9 %id)
CR625653 Placenta Cot 25-normalized .a 1 to 1606 2 to 1607 exact tiling clone,   1607/1607
(100 %)
0 diff
(100 %id)
BX372660 Neuroblastoma Cot 25-normalized .a 850 to 1628 778 to 1   tiling clone,   778/842
(92 %)
28 diff
(96.7 %id)
BX332082 Neuroblastoma Cot 25-normalized .a 861 to 1575 724 to 1       724/724
(100 %)
31 diff
(95.8 %id)
TI_43964032   .b 1 to 825 54 to 888   tiling clone, fully sequenced,   835/888
(94 %)
28 diff
(96.9 %id)
BI519992 brain, medulla .b 6 to 825 1 to 830   tiling clone, fully sequenced,   830/830
(100 %)
23 diff
(97.3 %id)
CN394074 embryonic stem cells, DMSO-treated H9 cellline .b 73 to 694 1 to 623       623/625
(99 %)
7 diff
(98.9 %id)
BM550988 duodenal adenocarcinoma, cell line, small intestine .b 87 to 863 1 to 779       779/1129
(68 %)
16 diff
(98.6 %id)
DA540855 lung .b 97 to 659 2 to 564   capped   563/564
(99 %)
1 diff
(99.9 %id)
DA894301 skeletal muscle .b 98 to 605 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA385948 thalamus .b 99 to 605 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DA894208 skeletal muscle .b 99 to 588 2 to 491   capped   490/490
(100 %)
0 diff
(100 %id)
DA909804   .b 99 to 677 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CR590698 Neuroblastoma Cot 25-normalized .b 107 to 1610 1 to 1504       1504/1504
(100 %)
0 diff
(100 %id)
CR620303 HeLa cells Cot 25-normalized .b 107 to 1628 1 to 1522       1522/1522
(100 %)
0 diff
(100 %id)
CR622484 Neuroblastoma Cot 25-normalized .b 107 to 1657 1 to 1551   tiling clone,   1551/1551
(100 %)
0 diff
(100 %id)
AL523733 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 107 to 955 1 to 842   fully sequenced,   844/844
(100 %)
5 diff
(99.5 %id)
AL527609 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 107 to 1021 1 to 903   fully sequenced,   905/905
(100 %)
4 diff
(99.6 %id)
CR604590 T cells (Jurkat cell line) .b 109 to 1646 1 to 1538       1538/1538
(100 %)
0 diff
(100 %id)
CR618213 Neuroblastoma Cot 25-normalized .b 109 to 1639 1 to 1531       1531/1531
(100 %)
0 diff
(100 %id)
BX385643 Neuroblastoma Cot 25-normalized .b 109 to 1234 1 to 1120       1120/1132
(98 %)
26 diff
(97.8 %id)
BX445771 T cells (Jurkat cell line) .b 109 to 1060 1 to 940       942/1010
(93 %)
28 diff
(97.3 %id)
BG826380 muscle, rhabdomyosarcoma .b 109 to 1071 1 to 955       955/955
(100 %)
36 diff
(96.3 %id)
AL526372 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 111 to 993 1 to 870       872/918
(94 %)
34 diff
(96.3 %id)
CN394075 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 115 to 430 1 to 316       316/316
(100 %)
1 diff
(99.7 %id)
BM008985 adenocarcinoma, Pancreas .b 116 to 993 1 to 883       883/883
(100 %)
11 diff
(98.8 %id)
TI_59386709   .b 117 to 993 63 to 944       882/882
(100 %)
10 diff
(98.9 %id)
TI_57220726   .b 118 to 1060 66 to 1009       944/1063
(88 %)
27 diff
(97.5 %id)
BI757781 brain .b 119 to 1060 1 to 943       943/997
(94 %)
21 diff
(97.9 %id)
BI759665 pooled colon, kidney, stomach .b 122 to 882 1 to 759       759/762
(99 %)
9 diff
(98.9 %id)
DA617041   .b 122 to 700 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
TI_57148344   .b 122 to 882 29 to 787       759/790
(96 %)
10 diff
(98.8 %id)
BI822670 pooled brain, lung, testis .b 125 to 972 1 to 847       847/853
(99 %)
13 diff
(98.5 %id)
TI_57198768   .b 125 to 972 69 to 915       847/921
(91 %)
19 diff
(98.0 %id)
BE253699 eye, retinoblastoma .b 126 to 882 1 to 757       757/793
(95 %)
15 diff
(98.2 %id)
BE298638 muscle, rhabdomyosarcoma .b 129 to 761 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
BX437971 neuroblastoma .b 131 to 1203 1 to 1057       1063/1102
(96 %)
19 diff
(98.3 %id)
BI520796 brain, medulla .b 820 to 944 126 to 1   fully sequenced,   126/126
(100 %)
6 diff
(95.3 %id)
TI_43964033   .b 820 to 1622 808 to 1   fully sequenced,   808/808
(100 %)
16 diff
(98.1 %id)
AL523732 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 925 to 1657 731 to 1   fully sequenced,   731/731
(100 %)
9 diff
(98.8 %id)
AL562940 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 991 to 1610 625 to 1   fully sequenced,   625/625
(100 %)
13 diff
(98.0 %id)
BM480273 eye, retinoblastoma .c 1 to 960 5 to 969 F55S Y56M E57K D58T R59A ... tiling clone,   965/1034
(93 %)
24 diff
(97.7 %id)
TI_57170819   .d 1 to 528 27 to 560   tiling clone,   539/561
(96 %)
8 diff
(98.6 %id)
BI830126 brain, medulla .d 1 to 528 1 to 533   tiling clone,   533/534
(99 %)
21 diff
(96.1 %id)
BX384389   .d 89 to 1003 1 to 907       907/915
(99 %)
22 diff
(97.6 %id)
CR604728 HeLa cells Cot 25-normalized .d 90 to 1806 1 to 1717   tiling clone,   1717/1717
(100 %)
0 diff
(100 %id)
NM_004468.3   .d 99 to 1800 1 to 1702   RefSeq, AAA   1702/1702
(100 %)
2 diff
(99.9 %id)
BI335331 cervical carcinoma cell line, cervix .d 130 to 943 8 to 824       815/825
(98 %)
21 diff
(97.5 %id)
DA965566 stomach .d 135 to 707 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CR617934 Neuroblastoma Cot 50-normalized .d 136 to 1780 1 to 1645       1645/1645
(100 %)
0 diff
(100 %id)
BX345084 Neuroblastoma Cot 50-normalized .d 136 to 1066 1 to 924       924/982
(94 %)
13 diff
(98.7 %id)
BX395304 Neuroblastoma Cot 50-normalized .d 136 to 1123 1 to 983       983/987
(99 %)
21 diff
(97.9 %id)
CR604640 Neuroblastoma Cot 25-normalized .d 141 to 1766 1 to 1626       1626/1626
(100 %)
0 diff
(100 %id)
AL523573 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 141 to 1013 1 to 867       867/1052
(82 %)
7 diff
(99.4 %id)
BQ708228 Spleen .d 144 to 825 13 to 696       684/961
(71 %)
12 diff
(98.8 %id)
BM760710 lymph node, stomach .d 145 to 753 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
AK290641 whole embryo, mainly head .d 146 to 1192 1 to 1047       1047/1047
(100 %)
1 diff
(100.0 %id)
DA569247 whole embryo, mainly head .d 147 to 955 2 to 817   capped   816/866
(94 %)
12 diff
(98.7 %id)
BM762853 lymph node, stomach .d 147 to 756 1 to 610       610/610
(100 %)
0 diff
(100 %id)
BM761621 lymph node, stomach .d 147 to 675 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BM831613 lymph node, stomach .d 147 to 668 1 to 521       521/521
(100 %)
3 diff
(99.5 %id)
BM842724 lymph node, stomach .d 147 to 787 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BM843641 lymph node, stomach .d 147 to 654 1 to 508       508/508
(100 %)
2 diff
(99.7 %id)
BM844155 lymph node, stomach .d 147 to 655 1 to 528       528/528
(100 %)
54 diff
(89.8 %id)
BM843181 lymph node, stomach .d 147 to 634 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BM843524 lymph node, stomach .d 147 to 838 1 to 692       692/692
(100 %)
0 diff
(100 %id)
BM845520 lymph node, stomach .d 147 to 484 1 to 337       337/337
(100 %)
1 diff
(99.8 %id)
BM844915 lymph node, stomach .d 147 to 538 1 to 392       392/392
(100 %)
0 diff
(100 %id)
BM846480 lymph node, stomach .d 147 to 708 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BM845115 lymph node, stomach .d 147 to 727 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA893325 skeletal muscle .d 147 to 449 2 to 305   capped   304/304
(100 %)
2 diff
(99.4 %id)
DA900001 skeletal muscle .d 147 to 607 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
TI_57235199   .d 150 to 1004 30 to 886       857/888
(96 %)
27 diff
(97.0 %id)
TI_57201806   .d 152 to 957 26 to 829       804/829
(96 %)
8 diff
(99.1 %id)
BM924990 pooled lung and spleen .d 153 to 1185 1 to 1044 R203P C224W K225Q V229E G234S ...     1044/1044
(100 %)
26 diff
(97.6 %id)
BI765876 pooled colon, kidney, stomach .d 154 to 1004 1 to 851       851/852
(99 %)
12 diff
(98.6 %id)
TI_57148706   .d 154 to 1004 1 to 851       851/852
(99 %)
12 diff
(98.6 %id)
DA571119 whole embryo, mainly head .d 155 to 981 2 to 828   capped   827/830
(99 %)
13 diff
(98.5 %id)
BI196243 brain, neuroblastoma .d 155 to 925 1 to 772       772/772
(100 %)
2 diff
(99.8 %id)
BG827162 muscle, rhabdomyosarcoma .d 155 to 816 1 to 661       661/661
(100 %)
2 diff
(99.7 %id)
BG826778 muscle, rhabdomyosarcoma .d 155 to 853 1 to 700       700/700
(100 %)
3 diff
(99.6 %id)
BC001351 Muscle, rhabdomyosarcoma .d 156 to 1800 1 to 1645   available from MGC, AAA   1645/1645
(100 %)
2 diff
(99.9 %id)
BC011697 Muscle, rhabdomyosarcoma .d 156 to 1800 1 to 1645   available from MGC, AAA   1645/1645
(100 %)
2 diff
(99.9 %id)
AW411342 muscle, rhabdomyosarcoma .d 156 to 821 11 to 676       666/676
(98 %)
6 diff
(99.2 %id)
BE297925 muscle, rhabdomyosarcoma .d 156 to 815 29 to 688       660/690
(95 %)
8 diff
(98.9 %id)
BI908945 leukocyte .d 156 to 1004 1 to 851       851/853
(99 %)
22 diff
(97.5 %id)
CR599922 Placenta Cot 25-normalized .d 158 to 1767 1 to 1610       1610/1610
(100 %)
0 diff
(100 %id)
CR601712 Neuroblastoma Cot 50-normalized .d 158 to 1758 1 to 1601       1601/1601
(100 %)
0 diff
(100 %id)
CR623890 Neuroblastoma Cot 25-normalized .d 158 to 1747 1 to 1590       1590/1590
(100 %)
0 diff
(100 %id)
AL526613 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 158 to 934 1 to 778   fully sequenced,   778/778
(100 %)
1 diff
(99.9 %id)
AL528550 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 158 to 934 1 to 778   fully sequenced,   778/778
(100 %)
6 diff
(99.3 %id)
AL550299 placenta, Placenta Cot 25-normalized .d 158 to 1101 1 to 945   fully sequenced,   945/945
(100 %)
7 diff
(99.3 %id)
CR590048 Neuroblastoma Cot 10-normalized .d 159 to 1767 1 to 1609       1609/1609
(100 %)
0 diff
(100 %id)
AL521289 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 159 to 957 1 to 797   fully sequenced,   797/797
(100 %)
4 diff
(99.5 %id)
BI822055 pooled brain, lung, testis .d 160 to 957 1 to 796       796/796
(100 %)
3 diff
(99.7 %id)
BQ651746 hepatocellular carcinoma, cell line, Liver .d 160 to 825 1 to 667       667/984
(67 %)
10 diff
(99.0 %id)
TI_57237782   .d 160 to 747 30 to 643       614/791
(77 %)
31 diff
(96.1 %id)
CR597013 Neuroblastoma Cot 25-normalized .d 161 to 1772 1 to 1612       1612/1612
(100 %)
0 diff
(100 %id)
CR619025 Placenta Cot 25-normalized .d 161 to 1791 1 to 1631       1631/1631
(100 %)
0 diff
(100 %id)
AL528415 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 161 to 1090 1 to 920   fully sequenced, AAA   920/920
(100 %)
5 diff
(99.5 %id)
BX324700 Placenta Cot 25-normalized .d 161 to 1013 1 to 849   fully sequenced,   849/849
(100 %)
9 diff
(99.0 %id)
CR607994 Neuroblastoma Cot 25-normalized .d 163 to 1768 1 to 1606       1606/1606
(100 %)
0 diff
(100 %id)
AL528520 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 163 to 934 1 to 772   fully sequenced,   772/772
(100 %)
6 diff
(99.3 %id)
AL551594 placenta, Placenta Cot 25-normalized .d 163 to 1008 1 to 844   fully sequenced,   844/844
(100 %)
3 diff
(99.7 %id)
CR616103 Neuroblastoma Cot 10-normalized .d 164 to 1734 1 to 1571       1571/1571
(100 %)
0 diff
(100 %id)
AL521266 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 164 to 1038 1 to 874   fully sequenced,   874/874
(100 %)
9 diff
(99.0 %id)
DR006536 Spleen .d 164 to 720 1 to 557       557/557
(100 %)
5 diff
(99.2 %id)
DB260336 uterus .d 164 to 710 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
CR592415 Neuroblastoma Cot 25-normalized .d 165 to 1772 1 to 1608       1608/1608
(100 %)
0 diff
(100 %id)
AL525946 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 165 to 934 1 to 768   fully sequenced,   768/768
(100 %)
2 diff
(99.8 %id)
CR622019 Neuroblastoma Cot 25-normalized .d 172 to 1772 1 to 1601       1601/1601
(100 %)
0 diff
(100 %id)
AL525463 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 172 to 934 1 to 762   fully sequenced, AAA   762/762
(100 %)
4 diff
(99.5 %id)
CA394494 eye, RPE/choroid .d 173 to 753 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
TI_57242970   .d 174 to 944 28 to 798       771/798
(96 %)
7 diff
(99.2 %id)
BF219981 muscle, rhabdomyosarcoma .d 175 to 825 1 to 652       652/660
(98 %)
4 diff
(99.4 %id)
BE313231 brain, neuroblastoma .d 175 to 744 1 to 570       570/571
(99 %)
1 diff
(99.9 %id)
BI914364 brain .d 178 to 944 1 to 767       767/767
(100 %)
1 diff
(99.9 %id)
CV805792 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 179 to 815 1 to 638       638/894
(71 %)
6 diff
(99.4 %id)
CR613498 Neuroblastoma Cot 25-normalized .d 180 to 1772 1 to 1593       1593/1593
(100 %)
0 diff
(100 %id)
AL526900 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 180 to 936 1 to 756   fully sequenced,   756/756
(100 %)
1 diff
(99.9 %id)
BQ930352 leiomyosarcoma, uterus .d 180 to 1082 1 to 908       908/909
(99 %)
17 diff
(98.2 %id)
BM562199 amelanotic melanoma, cell line, skin .d 181 to 824 1 to 647       647/1145
(56 %)
6 diff
(99.5 %id)
BU166659 melanotic melanoma, skin .d 207 to 1006 1 to 815       815/873
(93 %)
41 diff
(95.4 %id)
TI_57235520   .d 226 to 1091 33 to 896       864/902
(95 %)
14 diff
(98.5 %id)
BI908150 leukocyte .d 231 to 1091 1 to 859       859/865
(99 %)
9 diff
(99.0 %id)
U60116   .d 293 to 1801 8 to 1516 C82R S130I S140P K157N S166T ...     1509/1516
(99 %)
22 diff
(98.6 %id)
BX362976   .d 305 to 922 1 to 619       619/619
(100 %)
44 diff
(92.9 %id)
TI_1948091187   .d 324 to 825 122 to 623       502/1339
(37 %)
9 diff
(99.4 %id)
AF133732 skeletal muscle .d 325 to 1800 1 to 1476 R161S G197R S276F AAA   1476/1476
(100 %)
11 diff
(99.3 %id)
BT007052   .d 325 to 1166 1 to 842       842/843
(99 %)
1 diff
(99.9 %id)
CR457425   .d 325 to 1167 1 to 843 A252D     843/843
(100 %)
2 diff
(99.8 %id)
CV027169 mixed .d 325 to 703 1 to 379       379/379
(100 %)
3 diff
(99.3 %id)
BI860808 breast, mammary adenocarcinoma, cell line .d 349 to 1096 1 to 751       751/751
(100 %)
9 diff
(98.9 %id)
TI_57192794   .d 349 to 1096 54 to 804       751/751
(100 %)
9 diff
(98.9 %id)
Z19178 leg muscle, skeletal muscle .d 369 to 680 1 to 314       314/318
(98 %)
4 diff
(98.8 %id)
T34472 lung .d 390 to 594 1 to 205       205/205
(100 %)
0 diff
(100 %id)
AW951114   .d 391 to 952 1 to 561       561/562
(99 %)
3 diff
(99.5 %id)
TI_1948091063   .d 422 to 1166 879 to 126       754/1359
(55 %)
20 diff
(98.6 %id)
DA896466 skeletal muscle .d 429 to 988 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BM010854 amelanotic melanoma, cell line, skin .d 485 to 1334 1 to 846       846/855
(98 %)
17 diff
(98.1 %id)
TI_59383748   .d 486 to 1334 93 to 937       845/854
(98 %)
16 diff
(98.2 %id)
BF575467 muscle (skeletal) .d 533 to 1145 1 to 603       603/843
(71 %)
15 diff
(98.3 %id)
DA897905 skeletal muscle .d 550 to 1112 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BG489527 large cell carcinoma, lung .d 555 to 1412 1 to 852       852/859
(99 %)
39 diff
(95.5 %id)
Z19368 leg muscle, skeletal muscle .d 568 to 901 1 to 334       334/336
(99 %)
8 diff
(97.7 %id)
BQ650782 hepatocellular carcinoma, cell line, Liver .d 630 to 1392 13 to 781       769/934
(82 %)
20 diff
(97.9 %id)
TI_1948083758   .d 645 to 1041 135 to 535       399/1362
(29 %)
16 diff
(98.9 %id)
CV028981 mixed .d 655 to 1166 7 to 518       512/565
(90 %)
9 diff
(98.5 %id)
BX385642 Neuroblastoma Cot 25-normalized .d 656 to 1770 1114 to 1       1114/1114
(100 %)
44 diff
(96.1 %id)
BG470003 adenocarcinoma cell line, colon .d 661 to 1541 1 to 875       875/972
(90 %)
43 diff
(95.6 %id)
BX345083 Neuroblastoma Cot 50-normalized .d 674 to 1745 1062 to 1       1062/1064
(99 %)
34 diff
(96.9 %id)
BM460059 leiomyosarcoma, uterus .d 682 to 1435 33 to 791       759/1137
(66 %)
24 diff
(97.9 %id)
AW273408 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 692 to 1259 570 to 1       570/570
(100 %)
8 diff
(98.6 %id)
BM912309 amelanotic melanoma, cell line, skin .d 738 to 1165 1 to 429       429/1206
(35 %)
8 diff
(99.4 %id)
BM557043 amelanotic melanoma, cell line, skin .d 740 to 1734 1 to 1006       1006/1044
(96 %)
23 diff
(97.8 %id)
BM562353 amelanotic melanoma, cell line, skin .d 740 to 1063 1 to 326       326/1127
(28 %)
4 diff
(99.7 %id)
BX370513   .d 778 to 1546 1 to 776       776/970
(80 %)
43 diff
(95.6 %id)
CN300455 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 780 to 1147 1 to 368       368/368
(100 %)
1 diff
(99.8 %id)
BX445770 T cells (Jurkat cell line) .d 823 to 1767 948 to 1       948/1038
(91 %)
32 diff
(97.0 %id)
BM545780 ovary (pool of 3) .d 825 to 1768 33 to 979       949/979
(96 %)
33 diff
(96.7 %id)
BX355333 Neuroblastoma Cot 50-normalized .d 826 to 1302 927 to 457       471/532
(88 %)
33 diff
(93.8 %id)
TI_1948091188   .d 829 to 1166 458 to 121       338/1305
(25 %)
1 diff
(100.0 %id)
BX352681 Neuroblastoma Cot 10-normalized .d 867 to 1742 874 to 1       874/877
(99 %)
46 diff
(94.8 %id)
TI_154108156   .d 886 to 1804 992 to 84   AAA   909/950
(95 %)
16 diff
(98.4 %id)
BF837558 head_neck .d 895 to 1308 417 to 3     Submitted on the opposite strand 415/417
(99 %)
0 diff
(100 %id)
AL525660 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 904 to 1772 867 to 1   fully sequenced,   867/867
(100 %)
9 diff
(99.0 %id)
AL526160 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 904 to 1772 867 to 1   fully sequenced,   867/867
(100 %)
6 diff
(99.4 %id)
AL526734 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 904 to 1747 842 to 1   fully sequenced,   842/842
(100 %)
5 diff
(99.5 %id)
AL563163 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 904 to 1768 873 to 1   fully sequenced,   873/873
(100 %)
28 diff
(96.8 %id)
AL528549 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 904 to 1758 856 to 1   fully sequenced,   856/856
(100 %)
7 diff
(99.2 %id)
AL526865 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 906 to 1754 863 to 16   fully sequenced,   848/863
(98 %)
0 diff
(100 %id)
CN300453 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 926 to 1483 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
AL521288 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 927 to 1745 841 to 23   fully sequenced,   819/841
(97 %)
0 diff
(100 %id)
BQ675737 epidermoid carcinoma, cell line, salivary gland .d 947 to 1803 1 to 863       863/881
(97 %)
19 diff
(97.9 %id)
BM692392 eye, human retina .d 954 to 1383 7 to 436   fully sequenced,   430/436
(98 %)
8 diff
(98.2 %id)
BM695151 eye, human retina .d 956 to 1325 1 to 370   fully sequenced,   370/370
(100 %)
0 diff
(100 %id)
AA399349 ovarian tumor, ovary .d 965 to 1480 18 to 529       512/529
(96 %)
10 diff
(98.2 %id)
BM724047 eye, fetal eye .d 977 to 1430 1 to 456   fully sequenced,   456/456
(100 %)
3 diff
(99.4 %id)
AL551558 placenta, Placenta Cot 25-normalized .d 978 to 1747 788 to 24   fully sequenced,   769/792
(97 %)
3 diff
(99.7 %id)
AL521265 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 982 to 1734 753 to 1   fully sequenced,   753/753
(100 %)
12 diff
(98.5 %id)
BX324699 Placenta Cot 25-normalized .d 982 to 1791 807 to 1   fully sequenced,   807/807
(100 %)
16 diff
(98.1 %id)
TI_154103374   .d 1011 to 1800 873 to 90   AAA   784/955
(82 %)
15 diff
(98.5 %id)
BX374168   .d 1015 to 1806 796 to 1       796/889
(89 %)
23 diff
(97.5 %id)
AL523572 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1029 to 1458 786 to 359       428/1078
(39 %)
12 diff
(98.9 %id)
Z19179 leg muscle, skeletal muscle .d 1030 to 1333 306 to 2       305/306
(99 %)
0 diff
(100 %id)
AI375210 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1048 to 1800 763 to 12   AAA   752/752
(100 %)
36 diff
(95.3 %id)
CA447438 Chondrosarcoma, Left Pelvis .d 1049 to 1804 773 to 18   AAA   756/756
(100 %)
2 diff
(99.8 %id)
AL528387 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1060 to 1772 729 to 1   fully sequenced,   729/729
(100 %)
28 diff
(96.2 %id)
AL550271 placenta, Placenta Cot 25-normalized .d 1071 to 1758 689 to 8   fully sequenced,   682/689
(98 %)
22 diff
(96.9 %id)
BM987678 mixed .d 1075 to 1259 204 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 186/187
(99 %)
3 diff
(98.4 %id)
TI_154047646   .d 1081 to 1804 834 to 117   AAA   718/950
(75 %)
19 diff
(98.0 %id)
BX414240 T cells (Jurkat cell line) .d 1093 to 1777 690 to 1       690/779
(88 %)
29 diff
(96.3 %id)
CD366086 Alveolar Macrophage, lung .d 1112 to 1800 704 to 19   AAA   686/686
(100 %)
5 diff
(99.3 %id)
BF220053 muscle, rhabdomyosarcoma .d 1120 to 1755 636 to 1       636/636
(100 %)
8 diff
(98.8 %id)
BM726133 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1128 to 1535 1 to 408   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
CK725042 Chondrosarcoma, Left Pubic Bone .d 1182 to 1800 636 to 19   AAA   618/618
(100 %)
3 diff
(99.6 %id)
DB355859 whole embryo, mainly head .d 1216 to 1800 585 to 1       585/626
(93 %)
14 diff
(97.8 %id)
BF929252 nervous_tumor .d 1219 to 1362 1 to 145       145/145
(100 %)
1 diff
(99.4 %id)
CA431594 cell lines, Enchondroma .d 1261 to 1800 557 to 19   AAA   539/539
(100 %)
4 diff
(99.3 %id)
BX372964 Neuroblastoma Cot 50-normalized .d 1283 to 1780 501 to 1       501/528
(94 %)
18 diff
(96.6 %id)
AA112837 muscle, skeletal muscle .d 1291 to 1720 1 to 433       433/441
(98 %)
8 diff
(98.2 %id)
F25420 pectoral muscle (after mastectomy) .d 1293 to 1657 1 to 365       365/365
(100 %)
6 diff
(98.4 %id)
BM666921 eye, human retina .d 1295 to 1813 561 to 43   fully sequenced, AAA   519/540
(96 %)
10 diff
(98.2 %id)
F19221 pectoral muscle (after mastectomy) .d 1298 to 1655 1 to 353       353/353
(100 %)
7 diff
(98.1 %id)
BX499519 Liver .d 1299 to 1800 1 to 501   AAA   501/501
(100 %)
8 diff
(98.5 %id)
F29693 pectoral muscle (after mastectomy) .d 1317 to 1434 1 to 118       118/118
(100 %)
2 diff
(98.4 %id)
AA339689 brain .d 1329 to 1593 1 to 266       266/266
(100 %)
3 diff
(98.9 %id)
F19734 pectoral muscle (after mastectomy) .d 1348 to 1671 1 to 324       324/325
(99 %)
1 diff
(99.7 %id)
BM673637 eye, human retina .d 1353 to 1813 505 to 45   fully sequenced, AAA   461/487
(94 %)
6 diff
(98.8 %id)
F27757 pectoral muscle (after mastectomy) .d 1354 to 1686 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
AI368108 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1356 to 1802 452 to 6       447/452
(98 %)
0 diff
(100 %id)
BG054782 brain, glioblastoma (pooled) .d 1357 to 1800 445 to 1       445/445
(100 %)
10 diff
(97.8 %id)
AW451112   .d 1358 to 1804 464 to 18   AAA   447/447
(100 %)
3 diff
(99.4 %id)
AI089745 brain, glioblastoma (pooled) .d 1364 to 1800 452 to 16   AAA   437/437
(100 %)
3 diff
(99.4 %id)
AI819791 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1364 to 1809 469 to 24   tiling clone, AAA   446/446
(100 %)
20 diff
(95.6 %id)
AI336287 lung .d 1375 to 1802 431 to 6       426/460
(92 %)
0 diff
(100 %id)
F27145 pectoral muscle (after mastectomy) .d 1378 to 1694 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
F32680 pectoral muscle (after mastectomy) .d 1385 to 1768 1 to 384       384/384
(100 %)
3 diff
(99.3 %id)
F37408 pectoral muscle (after mastectomy) .d 1385 to 1769 1 to 385       385/385
(100 %)
4 diff
(99.0 %id)
AU145841 whole embryo, mainly head .d 1388 to 1800 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
AI672242 Kidney .d 1390 to 1803 424 to 13   AAA   412/412
(100 %)
3 diff
(99.3 %id)
F30996 pectoral muscle (after mastectomy) .d 1390 to 1696 1 to 307       307/307
(100 %)
2 diff
(99.4 %id)
CD174217 embryonic stem cells, WA01, passage 38 .d 1395 to 1800 13 to 418   AAA   406/418
(97 %)
6 diff
(98.6 %id)
CA412835 Chondrosarcoma Grade II, Left Pelvis .d 1399 to 1804 424 to 19   AAA   406/408
(99 %)
13 diff
(96.9 %id)
BU742091 eye, fetal eye .d 1400 to 1800 416 to 16   fully sequenced, AAA   401/401
(100 %)
10 diff
(97.6 %id)
AJ572024 pectoral muscle (after mastectomy) .d 1405 to 1796 1 to 392       392/392
(100 %)
1 diff
(99.8 %id)
F22696 pectoral muscle (after mastectomy) .d 1409 to 1773 1 to 365       365/365
(100 %)
7 diff
(98.1 %id)
AJ572022 pectoral muscle (after mastectomy) .d 1409 to 1798 12 to 401       390/401
(97 %)
6 diff
(98.6 %id)
AW008467 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1411 to 1803 412 to 20   AAA   393/393
(100 %)
8 diff
(98.0 %id)
AJ572306 pectoral muscle (after mastectomy) .d 1414 to 1797 1 to 384       384/384
(100 %)
0 diff
(100 %id)
F24433 pectoral muscle (after mastectomy) .d 1416 to 1613 1 to 198       198/198
(100 %)
0 diff
(100 %id)
AJ572401 pectoral muscle (after mastectomy) .d 1428 to 1797 1 to 370       370/370
(100 %)
0 diff
(100 %id)
AA192187 muscle, skeletal muscle .d 1429 to 1800 403 to 33   AAA   371/371
(100 %)
2 diff
(99.5 %id)
F25778 pectoral muscle (after mastectomy) .d 1431 to 1800 1 to 370   AAA   370/370
(100 %)
0 diff
(100 %id)
CB049963 Prostate .d 1433 to 1803 10 to 380   fully sequenced, AAA   371/380
(97 %)
6 diff
(98.5 %id)
AJ572454 pectoral muscle (after mastectomy) .d 1434 to 1795 1 to 361       361/361
(100 %)
2 diff
(99.5 %id)
AJ574435 pectoral muscle (after mastectomy) .d 1435 to 1802 1 to 368       368/371
(99 %)
4 diff
(99.0 %id)
F28631 pectoral muscle (after mastectomy) .d 1435 to 1674 1 to 240       240/240
(100 %)
2 diff
(99.2 %id)
BM918873 pooled pancreas and spleen .d 1436 to 1800 1 to 364   AAA   364/364
(100 %)
1 diff
(99.8 %id)
F32255 pectoral muscle (after mastectomy) .d 1436 to 1802 1 to 367       367/369
(99 %)
1 diff
(99.8 %id)
F33425 pectoral muscle (after mastectomy) .d 1436 to 1777 1 to 343       343/343
(100 %)
3 diff
(99.2 %id)
BF344928 brain, glioblastoma with EGFR amplification .d 1437 to 1800 1 to 367   AAA   367/367
(100 %)
4 diff
(99.0 %id)
F34629 pectoral muscle (after mastectomy) .d 1447 to 1736 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
F29419 pectoral muscle (after mastectomy) .d 1448 to 1733 1 to 286       286/286
(100 %)
1 diff
(99.7 %id)
AW008168 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1452 to 1800 367 to 19   AAA   349/349
(100 %)
19 diff
(94.6 %id)
F24520 pectoral muscle (after mastectomy) .d 1453 to 1789 1 to 337       337/337
(100 %)
0 diff
(100 %id)
F35278 pectoral muscle (after mastectomy) .d 1459 to 1772 1 to 314       314/314
(100 %)
0 diff
(100 %id)
F35233 pectoral muscle (after mastectomy) .d 1461 to 1780 1 to 320       320/320
(100 %)
10 diff
(96.9 %id)
AA622982 breast .d 1466 to 1802 343 to 5       339/343
(98 %)
0 diff
(100 %id)
AJ573781 pectoral muscle (after mastectomy) .d 1467 to 1803 1 to 337   AAA   337/337
(100 %)
2 diff
(99.5 %id)
AI203263 pooled germ cell tumors .d 1468 to 1802 342 to 8       335/342
(97 %)
0 diff
(100 %id)
AI671108 pooled germ cell tumors .d 1468 to 1802 344 to 8       337/344
(97 %)
0 diff
(100 %id)
F35302 pectoral muscle (after mastectomy) .d 1469 to 1667 1 to 199       199/199
(100 %)
1 diff
(99.5 %id)
AJ574595 pectoral muscle (after mastectomy) .d 1470 to 1797 1 to 328       328/328
(100 %)
0 diff
(100 %id)
CB049962 Prostate .d 1471 to 1803 366 to 34   fully sequenced, AAA   333/333
(100 %)
2 diff
(99.4 %id)
AA662492 normal prostate, Prostate .d 1473 to 1800 328 to 1       328/328
(100 %)
0 diff
(100 %id)
F33020 pectoral muscle (after mastectomy) .d 1476 to 1737 1 to 262       262/262
(100 %)
3 diff
(98.9 %id)
F37233 pectoral muscle (after mastectomy) .d 1476 to 1800 1 to 325       325/325
(100 %)
1 diff
(99.7 %id)
F22777 pectoral muscle (after mastectomy) .d 1477 to 1801 1 to 325       325/325
(100 %)
2 diff
(99.4 %id)
F21100 pectoral muscle (after mastectomy) .d 1488 to 1802 1 to 319       319/322
(99 %)
9 diff
(97.3 %id)
F35433 pectoral muscle (after mastectomy) .d 1492 to 1775 1 to 284       284/284
(100 %)
4 diff
(98.6 %id)
F29684 pectoral muscle (after mastectomy) .d 1504 to 1792 1 to 290       290/290
(100 %)
1 diff
(99.7 %id)
F27169 pectoral muscle (after mastectomy) .d 1505 to 1767 1 to 263       263/263
(100 %)
1 diff
(99.7 %id)
BM682565 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1505 to 1803 314 to 16   fully sequenced, AAA   299/299
(100 %)
5 diff
(98.4 %id)
F35344 pectoral muscle (after mastectomy) .d 1509 to 1800 1 to 291   AAA   291/291
(100 %)
4 diff
(98.7 %id)
AJ346338 pectoral muscle (after mastectomy) .d 1514 to 1802 1 to 289       289/294
(98 %)
2 diff
(99.4 %id)
AJ573656 pectoral muscle (after mastectomy) .d 1514 to 1802 1 to 289       289/296
(97 %)
2 diff
(99.4 %id)
AJ571963 pectoral muscle (after mastectomy) .d 1517 to 1800 1 to 284   AAA   284/284
(100 %)
0 diff
(100 %id)
F21897 pectoral muscle (after mastectomy) .d 1525 to 1801 1 to 278       278/278
(100 %)
1 diff
(99.7 %id)
AA328287   .d 1526 to 1757 1 to 232       232/232
(100 %)
1 diff
(99.6 %id)
AW961388   .d 1527 to 1808 1 to 282   AAA   282/282
(100 %)
0 diff
(100 %id)
AA852890 Bone, Hip .d 1531 to 1802 304 to 34       271/304
(89 %)
0 diff
(100 %id)
AA852898 Bone, Hip .d 1531 to 1802 304 to 34       271/304
(89 %)
0 diff
(100 %id)
AA553777 lung, lung tumor .d 1532 to 1805 275 to 3       273/275
(99 %)
0 diff
(100 %id)
AW411343 muscle, rhabdomyosarcoma .d 1533 to 1800 312 to 45   AAA   268/268
(100 %)
26 diff
(90.3 %id)
F17192 pectoral muscle (after mastectomy) .d 1534 to 1801 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
F37966 pectoral muscle (after mastectomy) .d 1541 to 1801 17 to 277       261/277
(94 %)
6 diff
(97.9 %id)
AJ571888 pectoral muscle (after mastectomy) .d 1550 to 1807 1 to 258   AAA   258/258
(100 %)
5 diff
(98.1 %id)
D80792 brain .d 1567 to 1800 1 to 232       232/232
(100 %)
3 diff
(98.8 %id)
AJ572676 pectoral muscle (after mastectomy) .d 1578 to 1803 4 to 229   AAA   226/229
(98 %)
7 diff
(97.0 %id)
F29870 pectoral muscle (after mastectomy) .d 1585 to 1791 1 to 207       207/207
(100 %)
1 diff
(99.6 %id)
AA629121   .d 1601 to 1802 203 to 3       201/203
(99 %)
0 diff
(100 %id)
AI354386 esophagus, squamous cell carcinoma .d 1613 to 1800 198 to 11   AAA   188/188
(100 %)
0 diff
(100 %id)
C01729   .d 1637 to 1800 1 to 164       164/164
(100 %)
0 diff
(100 %id)
F17016 pectoral muscle (after mastectomy) .d 1646 to 1805 1 to 160       160/160
(100 %)
7 diff
(95.7 %id)
F16912 pectoral muscle (after mastectomy) .d 1665 to 1801 1 to 137       137/137
(100 %)
4 diff
(97.1 %id)
F17116 pectoral muscle (after mastectomy) .d 1679 to 1808 1 to 130       130/131
(99 %)
3 diff
(97.8 %id)
BQ066977 brain .e -11 to 901 12 to 952 Q228P F230L V231S P232Y D233R ... tiling clone,   863/1009
(85 %)
27 diff
(97.4 %id)
CN300454 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 16 to 475 1 to 461       461/461
(100 %)
2 diff
(99.6 %id)
AK309179 thalamus .f 1 to 823 1 to 823 exact tiling clone,   823/823
(100 %)
1 diff
(99.9 %id)
BI114690 muscle, rhabdomyosarcoma .g 1 to 855 6 to 854 Q2L A4G A5S S6L P7A ... tiling clone,   858/959
(89 %)
43 diff
(95.6 %id)
BX406028 fetal liver, Liver .g 1 to 493 4 to 498   tiling clone,   498/633
(78 %)
30 diff
(95.3 %id)
BG395681 eye, retinoblastoma .g 216 to 915 1 to 718   tiling clone,   718/982
(73 %)
45 diff
(95.5 %id)
BG474843 eye, retinoblastoma .g 271 to 725 107 to 561   tiling clone,   455/561
(81 %)
8 diff
(98.6 %id)
BX406027 fetal liver, Liver .g 755 to 1418 665 to 1   tiling clone,   665/665
(100 %)
2 diff
(99.7 %id)
CR995020 T-Lymphocytes .h 1 to 530 5 to 535   tiling clone,   529/535
(98 %)
4 diff
(99.3 %id)
BC014501 Skin, melanotic melanoma, high MDR. .h 10 to 1475 1 to 1466 exact tiling clone, available from MGC, AAA   1466/1466
(100 %)
5 diff
(99.7 %id)
TI_57235337   .h 23 to 677 33 to 688       656/693
(94 %)
13 diff
(98.2 %id)
BI909275 leukocyte .h 24 to 677 1 to 655       655/660
(99 %)
9 diff
(98.7 %id)
AA852899 Bone, Hip .h 48 to 335 18 to 302       285/302
(94 %)
6 diff
(98.1 %id)
BQ434987 leiomyosarcoma, uterus .i 1 to 758 6 to 783 K87* tiling clone,   783/944
(82 %)
25 diff
(97.4 %id)
AV735171 pheochromocytoma .j 1 to 631 1 to 628 C113S tiling clone,   628/630
(99 %)
6 diff
(99.1 %id)
BY797665 eye .j 300 to 923 1 to 624   tiling clone,   624/624
(100 %)
6 diff
(99.1 %id)
BF904500 marrow .j 393 to 737 345 to 1   tiling clone, Submitted on the opposite strand 345/345
(100 %)
0 diff
(100 %id)
AA376745 small intestine .j 684 to 926 1 to 245   tiling clone,   245/245
(100 %)
3 diff
(98.8 %id)
DA822258 pericardium .k 1 to 575 2 to 576 A96T tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
BI022556 marrow .l-u 1 to 288 17 to 309 E13D G15V G16R Q17P T18D ... tiling clone,   293/312
(93 %)
14 diff
(95.6 %id)
BI021218 marrow .l-u 9 to 285 282 to 1   tiling clone,   282/283
(99 %)
8 diff
(97.2 %id)
AL556577 placenta Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
AL578805 placenta Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
AA460437   Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
AA460438   Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
AI380631 B-cell, chronic lymphotic leukemia Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
BE258442 eye, retinoblastoma Gene FHL3, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI